RHJA
STAB

Rice Hall James & Associates’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Rice Hall James & Associates’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,862
Closed -$184K – 316
2013
Q4 		$184K Buy
7,862
+4,785
+156% +$130K 0.01% 294
2013
Q3 		$97K Sell
3,077
-422
-12% -$14K 0.01% 271
2013
Q2 		$111K Buy
+3,499
New +$120K 0.01% 269

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Rice Hall James & Associates's STAB Position: Q1 2014 in Review

Rice Hall James & Associates sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2014, closing a stake of 7,862 shares — an estimated $184K sold.

Rice Hall James & Associates first reported a position in STAB in Q2 2013 and held it in 3 quarters. The position peaked at $184K in Q4 2013. 35 funds tracked by Wall St. Rank hold STAB as of Q1 2014.

  • Rice Hall James & Associates reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Rice Hall James & Associates sold 7,862 Statera Biopharma, Inc. Common Stock shares in Q1 2014, an estimated $184K.
  • Rice Hall James & Associates first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Rice Hall James & Associates's Statera Biopharma, Inc. Common Stock position peaked at $184K in Q4 2013.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2014.

Based on Rice Hall James & Associates's 13F filing for Q1 2014, filed 2 May 2014.